The Sienna Antigen test is good for all variants of Covid-19 Sars 2:
Covid-19, Alpha, Delta, Delta+ since it detects an integral part of the Nucleocapsid That is Common to all Covid-19 Variants
The Sienna™ COVID-19 Antigen Rapid Test Cassette is a rapid chromatographic immunoassay intended for the qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in direct nasopharyngeal swab (NP) specimens from individuals who are suspected of COVID-19 by their healthcare provider within the first six days of symptom onset.
This antigen test is authorized for use at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation.
The Sienna Antigen Rapid test is the number one supported Rapid Antigen test from the WHO. This test has full Approval from the Government for sale in over 80 Countries, which includes all of Europe, Mexico, Canada, Asia, Africa, the Middle East, and also South America. It's the second largest selling test for SARS-CoV-2 Antigen in Germany, which has one of the most difficult approval processes in the world. DNA Analytical Services is currently selling Sienna products in the United States, UK, Africa, The Middle East, South America & Europe. With the Sienna test, in less than 15 minutes, a positive or negative Covid-19 result is displayed clearly, along with a control result , which allows the tester to know the specimen was accurately collected via the nasal swab.
Reliable & Accurate Results: